Page 1

FOR IMMEDIATE RELEASE Contact : Chas Cook ( investors ) – 336-436-5076 Investor@Labcorp.com ● labcorp ● Christopher Allman - Bradshaw ( media ) — 336-436-8263 Media@Labcorp.com Labcorp Announces 2021 Second Quarter Results Company Raises Full Year Guidance Revenue : Q2 of $ 3.8 billion , versus $ 2.8 billion last year Diluted EPS : Q2 of $ 4.76 , versus $ 2.37 last year Adjusted EPS : Q2 of $ 6.13 , versus $ 2.57 last year Free Cash Flow : Q2 of $ 390 million , versus $ 272 million last year Acquired remaining ownership interest in OmniSeq , bolstering oncology portfolio Agreed to purchase the outreach laboratory business of a Minnesota - based hospital Full Year 2021 Guidance : Revenue raised to range of 6.5 % to 9.0 % ; Adjusted EPS raised to range of $ 21.50 to $ 25.00 ; Free Cash Flow raised to range of $ 1.95 billion to $ 2.15 billion BURLINGTON , N.C. , July 29 , 2021 - Labcorp ( NYSE : LH ) , a leading life sciences company , today announced results for the second quarter ended June 30 , 2021 , and raised full - year guidance . " Our strategy focusing on science , innovation and technology led to strong second quarter results as we continued to advance health care and patient experiences , " said Labcorp Chairman and CEO Adam Schechter . " Patients and pharmaceutical clients accelerated their return to normal health care and business activities , which drove 46 % revenue growth in our base business . In light of our second quarter performance and improved outlook , we are raising full - year financial guidance . " - more -